<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA) antibodies have been shown to be directed to protein-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> complexes </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we report on LA antibodies from patients with the 'antiphospholipid' syndrome (APS), that are directed to prothrombin and beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I, but not to the complexes of these plasma proteins to anionic <z:chebi fb="1" ids="16247">phospholipids</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>The anti-prothrombin antibodies studied had different reactivities in two clotting assays: the dilute Russell's viper venom time (dRVVT) and the dilute kaolin clotting time (dKCT) </plain></SENT>
<SENT sid="3" pm="."><plain>Anti-prothrombin and anti-beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (anti-beta2GPI) antibodies, affinity-purified from one patient with APS were not cross-reactive and had different effects in the dRVVT and dKCT clotting tests </plain></SENT>
<SENT sid="4" pm="."><plain>Polyclonal anti-prothrombin antibodies, affinity-purified on a prothrombin column, from two patients with prothrombin reactivity in their plasma, have affinity constants to prothrombin of 104 and 192 nM </plain></SENT>
<SENT sid="5" pm="."><plain>The patient with affinity-purified antibodies to prothrombin and beta2GPI, had affinity constants to prothrombin and beta2GPI, respectively, of 192 nM and 3030 nM, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>LA antibodies are a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> population of antibodies that have different immunological specificities and clotting test reactivities in different patients </plain></SENT>
</text></document>